A new impact framework for investors in life sciences bridges financial returns and patient outcomes

Philip Brainin

doi:10.1038/s41587-025-02726-5

A new impact framework for investors in life sciences bridges financial returns and patient outcomes

Philip Brainin^*

^*Corresponding author for this work

Department of Cardiology

Abstract

A new model for quantifying the impact of capital investments in life science interventions could help investors, policymakers and healthcare stakeholders to assess, monitor and optimize the societal impact of their investments.

Original language	English
Journal	Nature Biotechnology
Volume	43
Issue number	7
Pages (from-to)	1041-1046
Number of pages	6
ISSN	1087-0156
DOIs	https://doi.org/10.1038/s41587-025-02726-5
Publication status	Published - Jul 2025

Access to Document

10.1038/s41587-025-02726-5

Cite this

@article{503861f9f74d443299d00572ddc95524,

title = "A new impact framework for investors in life sciences bridges financial returns and patient outcomes",

abstract = "A new model for quantifying the impact of capital investments in life science interventions could help investors, policymakers and healthcare stakeholders to assess, monitor and optimize the societal impact of their investments.",

author = "Philip Brainin",

note = "Publisher Copyright: {\textcopyright} Springer Nature America, Inc. 2025.",

year = "2025",

month = jul,

doi = "10.1038/s41587-025-02726-5",

language = "English",

volume = "43",

pages = "1041--1046",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Research",

number = "7",

}

TY - JOUR

T1 - A new impact framework for investors in life sciences bridges financial returns and patient outcomes

AU - Brainin, Philip

N1 - Publisher Copyright: © Springer Nature America, Inc. 2025.

PY - 2025/7

Y1 - 2025/7

N2 - A new model for quantifying the impact of capital investments in life science interventions could help investors, policymakers and healthcare stakeholders to assess, monitor and optimize the societal impact of their investments.

AB - A new model for quantifying the impact of capital investments in life science interventions could help investors, policymakers and healthcare stakeholders to assess, monitor and optimize the societal impact of their investments.

UR - https://www.scopus.com/pages/publications/105010848083

U2 - 10.1038/s41587-025-02726-5

DO - 10.1038/s41587-025-02726-5

M3 - Comment/debate

C2 - 40664849

AN - SCOPUS:105010848083

SN - 1087-0156

VL - 43

SP - 1041

EP - 1046

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 7

ER -

A new impact framework for investors in life sciences bridges financial returns and patient outcomes

Abstract

Access to Document

Other files and links

Fingerprint

Cite this